优化发酵条件,以生产复合铁乙酶BpFaeT132C-D143C
Jinghao Ma1, Rana Abdul Basit1, Sihan Yuan1
1Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, China.
Folia microbiologica
|September 16, 2024
概括
烯酸乙酶 (FAE) 是关键酶,用于分解纤维素. 这项研究优化了大肠杆菌中BpFaeT132C-D143C的发酵条件,使酶活性增加了6.6倍.
科学领域:
- 生物技术是生物技术.
- 酵素工程是什么? 酶工程是什么
- 工业微生物学 工业微生物学
背景情况:
- 烯酸乙酶 (FAE) 对于降解纤维素和生产有价值的酸至关重要.
- 目前,低酶产量限制了FAE的工业应用.
- 优化表达条件对于提高FAE生产至关重要.
研究的目的:
- 为了优化发酵条件,在*Escherichia coli*中高水平表达热稳定的铁乙酶 (BpFaeT132C-D143C).
- 为潜在的工业应用显著增加BpFae的酶产量和活性.
主要方法:
- 采用单因素设计来选具有影响力的参数.
- 利用普莱克特-伯曼设计来识别影响酶活性的关键因素.
- 应用最的上升路径和响应表面方法,以进一步优化发酵条件.
主要成果:
- 确定了诱导后温度,诱导前期和诱导后期作为关键因素.
- 在优化条件下,BpFaeT132C-D143C活动增加了6.6倍,达到3.58 U/ml.
- 在3L发酵器 (1.52U/ml) 中成功表达,主要在细胞质中细胞内定位.
结论:
- 优化的发酵策略显著提高了BpFaeT132C-D143C产量和大肠杆菌中的活性.
- 这项工作为在农业废物处理中利用BpFae提供了基础.
- 改进的酶生产是FAE更广泛的工业应用的关键一步.
相关概念视频
Bioreactor Controls-III
71
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
71
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
Upstream Processing
103
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
103
Production of Organic Acids
111
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
111
Production of Antibiotics
285
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
285
Production of Pharmaceuticals
100
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
100


